STRATEC Biomedical AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
STRATEC Biomedical AG
24.02.2012 20:29
Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
With letter dated February 23, 2012, Allianz Global Investors
Kapitalanlagegesellschaft mbH, Frankfurt/Main, Germany, has notified us
pursuant to section 21 (1) sentence 1 of the German Securities Trading Act
(WpHG) as follows:
'We hereby give notice pursuant to section 21 (1) sentence 1 of the German
Securities Trading Act (WpHG) that our voting rights in STRATEC Biomedical
AG, Gewerbestr. 37, 75217 Birkenfeld, fell below the threshold of 3% on
February 22, 2012 and on that day amount to 2.999% of all voting rights of
the Company (this reflects 350,161 of all 11,674,895 voting rights).
With respect to our voting rights, 0.25% of all voting rights (this
reflects 29,745 of all 11,674,895 voting rights) are attributed to us
pursuant to section 22 (1) sentence 1 number 6 of the German Securities
Trading Act (WpHG).
Voting rights pursuant to section 17 (1) number 7 of the German Securities
Trading Reporting and Insider Register Ordinance (WpAIV) were not
acquired.'
24.02.2012 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
Language: English
Company: STRATEC Biomedical AG
Gewerbestr. 37
75217 Birkenfeld
Germany
Internet: www.stratec.com
End of Announcement DGAP News-Service
back